z-logo
Premium
The incretin effect, GLP‐1 analogues and DPP‐4 inhibitors
Author(s) -
Banham Stephen
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.817
Subject(s) - incretin , medicine , type 2 diabetes , pharmacology , dipeptidyl peptidase 4 , action (physics) , glucagon like peptide 1 , diabetes mellitus , endocrinology , physics , quantum mechanics
In this short article, the author explains the reduced ‘incretin effect’ in type 2 diabetes and the mode of action of GLP‐1 analogues and DPP‐4 inhibitors. Copyright © 2011 Wiley Interface Ltd

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here